Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform

PURPOSE: Lung cancer remains the leading cancer-associated deaths worldwide. Cisplatin (CIS) was often used in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). Prodrug is an effective strategy to improve the efficiency of drugs and reduce the toxicity. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zhen, Li, Juan, Zhu, Budong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602907/
https://www.ncbi.nlm.nih.gov/pubmed/33149550
http://dx.doi.org/10.2147/DDDT.S251749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602907/
https://www.ncbi.nlm.nih.gov/pubmed/33149550
http://dx.doi.org/10.2147/DDDT.S251749

Ejemplares similares